Exploiting the defensive sugars of HIV-1 for drug and vaccine design

被引:204
|
作者
Scanlan, Christopher N.
Offer, John
Zitzmann, Nicole
Dwek, Raymond A.
机构
[1] Univ Oxford, Glycobiol Inst, Oxford OX1 3QU, England
[2] Univ Oxford, Scripps Oxford Lab, Dept Biochem, Oxford OX1 3QU, England
关键词
D O I
10.1038/nature05818
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antigens on the virus's surface. Intriguingly, however, recent findings suggest that these carbohydrates, which have evolved to protect HIV and promote its transmission, are also attractive therapeutic targets.
引用
收藏
页码:1038 / 1045
页数:8
相关论文
共 50 条
  • [31] Broadly neutralizing antibodies and vaccine design against HIV-1 infection
    Wang, Qian
    Zhang, Linqi
    FRONTIERS OF MEDICINE, 2020, 14 (01) : 30 - 42
  • [32] Challenges in the Design of a T Cell Vaccine in the Context of HIV-1 Diversity
    Tongo, Marcel
    Burgers, Wendy A.
    VIRUSES-BASEL, 2014, 6 (10): : 3968 - 3990
  • [33] New results may help design effective HIV-1 vaccine
    Morris, K
    LANCET, 1999, 353 (9151): : 471 - 471
  • [34] Immunogenic selection of HIV-1 MPER epitopes for improved vaccine design
    L Wieczorek
    M Rao
    K Peachman
    N Steers
    M Marovich
    N Michael
    V Polonis
    V Rao
    Retrovirology, 9
  • [35] An immunology-based approach to the design of an HIV-1 preventative vaccine
    Gray, CM
    Puren, AJ
    SOUTH AFRICAN JOURNAL OF SCIENCE, 2000, 96 (06) : 347 - 350
  • [36] A Novel Vaccine Design for Inducing Robust HIV-1 Specific Immunity
    Chen, Z.
    Zhou, J.
    Wang, H.
    Tan, Z.
    Liu, H.
    Lu, X.
    Kang, Y.
    Du, Y.
    Liu, L.
    Xu, Y.
    Chen, L.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A106 - A107
  • [37] CTL ontogeny and viral escape: implications for HIV-1 vaccine design
    Yang, OO
    TRENDS IN IMMUNOLOGY, 2004, 25 (03) : 138 - 142
  • [38] Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design
    Joel Finney
    Garnett Kelsoe
    Retrovirology, 15
  • [39] Immunogenic selection of HIV-1 MPER epitopes for improved vaccine design
    Wieczorek, L.
    Rao, M.
    Peachman, K.
    Steers, N.
    Marovich, M.
    Michael, N.
    Polonis, V.
    Rao, V.
    RETROVIROLOGY, 2012, 9
  • [40] HIV-1 Nef structure may help in drug design
    不详
    LANCET, 1996, 347 (9007): : 1032 - 1032